See the Full Respiratory Picture
Continuously measure lung sounds, including cough and wheeze, from anywhere with the RESP® Biosensor
As Featured In
Quantify Cough and Lung Sounds
Stethoscope auscultation is key in identifying abnormal sounds to diagnose and monitor respiratory diseases, yet it has been limited to in-person, episodic visits. The RESP® Biosensor is the first FDA-cleared device to provide a continuous, passive measurement of patients’ lung sounds from hospital to home.
For Health Systems
Enhance surveillance and management of patients with chronic respiratory diseases
For Clinical Trials
Strengthen insight into treatment response alongside patient-reported outcomes
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Wearable biosensor passively and continuously collects lung sounds and physiological data
RESP® Cloud
Captured data are securely and wirelessly transferred to HIPAA-compliant cloud for overread
Patient Reports
Client receives detailed patient reports
1M+
Lung Sounds Captured
30M+
Breaths Captured
4
35
2
1
The Award-Winning Digital Health Technology for Lung Health
Privacy & Security
Designed for Daily Life
Low-burden, discreet design aids patient comfort while accurately collecting data in the real world.
Global Experience
Used in patients and subjects in four continents and 35 languages.
Beyond Cough
Extended capabilities beyond cough frequency include intensity, bouts, lung sounds and vitals* for a fuller understanding of patient health.
Clinically Validated Accuracy
*Measurement not FDA-cleared
FAQ
Frequently Asked Questions and Technical Specifications
News & Resources
Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained
Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects' cough. As drug developers consider including cough frequency as an endpoint in their studies,...
Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema
The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema and prevention of complications in critically ill ICU patients. Philadelphia, PA, February 20, 2025 — Strados Labs, a medical technology company focused on improving...
Why the Tegaderm™ Adhesive is a Trusted, Patient-Friendly Solution for the RESP® Biosensor
In research studies and healthcare settings, minimizing patient burden is essential for reliable data collection with wearables and devices. At Strados Labs, we understand the importance of these factors with the RESP® Biosensor, which is designed to continuously...
Let's Talk
Speak to one of our respiratory experts to learn more